×
About 625 results

ALLMedicine™ Myoclonic Epilepsy Center

Research & Reviews  107 results

Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retro...
https://doi.org/10.1016/j.seizure.2022.05.005
Seizure Kılıç B, Serdaroğlu E et. al.

May 21st, 2022 - Valproic acid (VPA) is frequently used and effective in juvenile myoclonic epilepsy (JME). Recently, levetiracetam (LEV) has been suggested as a monotherapy in JME. This study aimed to evaluate antiseizure medication (ASM) use in patients with JME...

Aberrant dynamic structure-function relationship of rich-club organization in treatment...
https://doi.org/10.1002/hbm.25873
Human Brain Mapping; Liu G, Zheng W et. al.

Apr 14th, 2022 - Neuroimaging studies have shown that juvenile myoclonic epilepsy (JME) is characterized by impaired brain networks. However, few studies have investigated the potential disruptions in rich-club organization-a core feature of the brain networks. Mo...

Seizure and social outcomes in patients with juvenile myoclonic epilepsy (JME).
https://doi.org/10.1016/j.seizure.2022.03.002
Seizure Asadi-Pooya AA, Rostamihosseinkhani M et. al.

Mar 9th, 2022 - To investigate the seizure outcome in patients with juvenile myoclonic epilepsy (JME) and its associated factors. We also investigated the social outcome of these patients. This was a retrospective study. All patients with a diagnosis of JME were ...

Comparative analysis of background EEG activity in juvenile myoclonic epilepsy during v...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827290
BMC Neurology; Moon JU, Lee JY et. al.

Feb 11th, 2022 - By definition, the background EEG is normal in juvenile myoclonic epilepsy (JME) patients and not accompanied by other developmental and cognitive problems. However, some recent studies using quantitative EEG (qEEG) reported abnormal changes in th...

Higher order visual dysfunction and myoclonic-atonic seizure: an atypical presentation ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830194
BMJ Case Reports; Mukherjee D, Bhattacharyya D et. al.

Feb 11th, 2022 - Neuronal ceroid lipofuscinosis is a rare childhood neurodegenerative disease, classified under the spectrum of progressive myoclonic epilepsy (PME). Cognitive decline, seizures including myoclonus, vision loss and ataxia are the commonly described...

see more →

Drugs  143 results

Levetiracetam - levetiracetam tablet-Major Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22de2626-eef5-47a0-a254-10837e5296a3

Jun 21st, 2022 - Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older ( 1.1) Levetiracetam is indicated for adjunctive therapy for the treatment of: •Myoclonic seizures in patients 12 years of age and older wi...

Levetiracetam - levetiracetam solution-Pharmaceutical Associates, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9dca1330-52ca-47a4-a134-ec55c9d5786d

Jun 20th, 2022 - Levetiracetam Oral Solution USP is indicated for the treatment of partial-onset seizures in patients 1 month of age and older ( 1.1) Levetiracetam Oral Solution USP is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in pa...

Levetiracetam - levetiracetam tablet, film coated-Rising Pharma Holdings, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2f5416c-631d-48cc-a6ce-f998c7217d70

Jun 8th, 2022 - Indications & Usage Section Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older (1.1) Levetiracetam is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12...

Levetiracetam - levetiracetam tablet, film coated-Bryant Ranch Prepack
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=90e01877-abcb-4697-a7ed-9afe5ee77050

Jun 6th, 2022 - Levetiracetam tablets USP are indicated for the treatment of partial-onset seizures in patients 1 month of age and older (1.1) Levetiracetam tablets USP are indicated for adjunctive therapy for treatment of: Partial onset seizures in patients one ...

Levetiracetam - levetiracetam tablet, film coated-ScieGen Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1d71212b-ac97-4a61-8192-8e8303540019

May 31st, 2022 - Levetiracetam is indicated for the treatment of partial-onset seizures in patients 1 month of age and older ( 1.1) Levetiracetam is indicated for adjunctive therapy for the treatment of: Myoclonic seizures in patients 12 years of age and older wit...

see more →